Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2009 Feb;21(2):225–229. doi: 10.1097/MEG.0b013e32831101b7

Table 2.

Characteristics of case series patients.

Patient Genotype Fibrosis stage at initial biopsy Fibrosis stage at time of HCC excision Years between biopsies Alcohol use? Treatment type (duration in weeks) SVR? Months from SVR to HCC diagnosis
1 1b 2 2 0 Prior PEG-IFN/RVN (48) Yes 1
2 3 3 3 6 Prior Rebetron (24),
PEG-IFN/RVN (48)		 Yes 37
3 1 2 4 2 Prior PEG-IFN/RVN (48) Yes 10
4 2b 2–3 Unknown N/A None Rebetron (24),
PEG-IFN/RVN (48)		 Yes 6
5 2b/4e 3 Unknown N/A None Rebetron (24),
Rebetron (12)		 Yes 68